GRTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GRTX shares is 1, representing N/A of the company's common stock.

GSA CAPITAL PARTNERS LLP, in the last quarter, reduced its stake in GRTX by -6.68% restricting it's holding to 3.63 million shares of worth nearly $509.00K. BLACKROCK INC. also lessened -0.12% of the GRTX shares from its portfolio, reducing its holding to 357.19 thousand shares of worth $50.01K. XTX TOPCO LTD also shunned GRTX shares holding by -36.45% last quarter which brought its holding to 25.25 thousand shares worth $3.53K.

As per its latest 13F filing, ATOM INVESTORS LP increased its stake in GRTX by 100% in the last quarter. The institutional holder raised its holding to 356.2 thousand shares having worth more than $49.87K. UBS GROUP AG also added 2,302.8% more shares of GRTX to its portfolio, raising its holding to 293.5 thousand shares of worth $41.09K. SUSQUEHANNA INTERNATIONAL GROUP, LLP also increased its GRTX shares holding by 100% which brought its holding to 286.18 thousand shares worth $40.07K.

The insider with the most stakes in GRTX is Schneid Yair , 10 percent owner at the company. Additionally, GRTX stock is highly held by CHANG NANCY T and 10 percent owner New Enterprise Associates 14, L.P. among others.

Company executives, directors, and other insiders own 45.69% percent of Galera Therapeutics, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which GRTX insiders have sold stock, totaling 67.02K shares. Insiders that have sold shares include SORENSEN MEL, HOLMLUND JON T, and NOVO HOLDINGS A/S.

There have been 1 transaction(s) during the past 6-months in which Galera Therapeutics, Inc. insiders have bought stock, totalling 7644932 shares

Around 7.91M Galera Therapeutics, Inc. shares are held by insiders, which represents about 45.69% of GRTX stock.

GRTX 10 percent owner, Schneid Yair holds the largest portfolio of the company's shares. GRTX shares owned by Schneid total nearly 10.72 million.

GSA CAPITAL PARTNERS LLP is the largest institutional owner in GRTX which holds 3.63 million shares worth $509.00K or 8.15% of the total GRTX shares outstanding followed by BLACKSTONE INC. with ownership of 1.68 million shares representing 3.77% of the GRTX ownership. ABRDN PLC is the third largest stakeholder with 898.37 thousand shares or 2.02% of the ownership worth more than $125.77K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GRTX is concerned, it is a stock which is optionable.

Number of GRTX shares short is 2.12M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 54.39M shares of GRTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GRTX has 39.94M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GRTX is 1.16.